Transgene SA reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 4.76 million compared to EUR 6.09 million a year ago. Net loss was EUR 15.9 million compared to EUR 15.28 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.21 EUR | -5.47% | -12.45% | -11.68% |
Apr. 10 | Transgene: presents vaccine results at AACR | CF |
Mar. 28 | Transgene CFO Steps Down; Successor Assumes Office | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.68% | 130M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- TNG Stock
- News Transgene
- Transgene SA Reports Earnings Results for the Half Year Ended June 30, 2023